Page last updated: 2024-08-26

oxoglaucine and Coxsackie Virus Infections

oxoglaucine has been researched along with Coxsackie Virus Infections in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Galabov, AS; Stoyanova, A1
Galabov, AS; Nikolova, I; Stoyanova, A1
Galabov, AS; Vassileva-Pencheva, R1
Dimitrov, V; Dobrikov, G; Galabov, AS; Nikolova, I; Philipov, S; PĆ¼rstinger, G; Stoyanova, A1

Other Studies

4 other study(ies) available for oxoglaucine and Coxsackie Virus Infections

ArticleYear
Effect of Consecutive Alternating Administration of a Triple Combination of Anti-Enteroviral Compounds in Mice Infected with Coxsackievirus B3.
    Pathogens and disease, 2020, 11-23, Volume: 78, Issue:9

    Topics: Animals; Antiviral Agents; Apomorphine; Cell Line; Coxsackievirus Infections; Disease Models, Animal; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Enterovirus B, Human; Humans; Mice; Nitriles; Oxadiazoles; Oxazoles; Virus Replication

2020
Effect of consecutive alternating administration (CAA) of a triple anti-enteroviral combination on Coxsackievirus B1 neuroinfection in mice.
    Antiviral research, 2015, Volume: 121

    Topics: Animals; Antiviral Agents; Apomorphine; Brain; Central Nervous System Infections; Coxsackievirus Infections; Disease Models, Animal; Drug Resistance, Viral; Drug Therapy, Combination; Enterovirus B, Human; Guanidine; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Survival Analysis; Treatment Outcome

2015
Effectiveness of the Consecutive Alternating Administration Course of a Triple Antiviral Combination in Coxsackievirus B3 Infections in Mice.
    Drug research, 2016, Volume: 66, Issue:12

    Topics: Animals; Animals, Newborn; Antiviral Agents; Apomorphine; Coxsackievirus Infections; Drug Therapy, Combination; Enterovirus B, Human; Guanidine; Isoxazoles; Mice; Mice, Inbred ICR

2016
Anti-enteroviral triple combination of viral replication inhibitors: activity against coxsackievirus B1 neuroinfection in mice.
    Antiviral chemistry & chemotherapy, 2015, Volume: 24, Issue:5-6

    Topics: Animals; Antiviral Agents; Apomorphine; Cells, Cultured; Coxsackievirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Enterovirus B, Human; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Nitriles; Oxadiazoles; Oxazoles; Virus Replication

2015